Blood pressure changes after renal denervation at 10 European expert centers

[1]  G. Hindricks,et al.  Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. , 2014, International journal of cardiology.

[2]  S. Kjeldsen,et al.  Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood Pressure , 2013, Hypertension.

[3]  E. Vink,et al.  Eligibility for percutaneous renal denervation: the importance of a systematic screening , 2013, Journal of hypertension.

[4]  E. Schiffrin,et al.  Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. , 2013, Journal of the American College of Cardiology.

[5]  E. O’Brien,et al.  Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence , 2013, Expert review of cardiovascular therapy.

[6]  John P. A. Ioannidis,et al.  Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review , 2013, European journal of clinical investigation.

[7]  T. Lüscher,et al.  Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter , 2013, European heart journal.

[8]  S. Bertog,et al.  Renal artery stenosis after renal sympathetic denervation. , 2012, Journal of the American College of Cardiology.

[9]  G. Bobrie,et al.  Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. , 2012, Journal of the American College of Cardiology.

[10]  F. Sweep,et al.  Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series , 2012, Hypertension.

[11]  Deepak L. Bhatt,et al.  Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial , 2012, Clinical cardiology.

[12]  J. Staessen,et al.  Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant Hypertension , 2012, Hypertension.

[13]  D. Blondin,et al.  Secondary rise in blood pressure after renal denervation , 2012, The Lancet.

[14]  H. Krum,et al.  Renal denervation in moderate to severe CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[15]  P. Anyfanti,et al.  Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. , 2012, Journal of hypertension.

[16]  H. Benamer,et al.  Expert consensus: Renal denervation for the treatment of hypertension. , 2012, Diagnostic and Interventional Imaging.

[17]  G. Parati,et al.  ESH position paper: renal denervation - an interventional therapy of resistant hypertension. , 2012, Journal of hypertension.

[18]  M. Gawaz,et al.  Effects of Renal Sympathetic Denervation on 24-hour Blood Pressure Variability , 2012, Front. Physio..

[19]  G. Bobrie,et al.  Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[20]  C. Gleissner.  Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis , 2011, Front. Physio..

[21]  V. Somers,et al.  Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea , 2011, Hypertension.

[22]  Symplicity Htn Investigators,et al.  Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.

[23]  E. O’Brien,et al.  Ambulatory Blood Pressure Monitoring in 9357 Subjects From 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women , 2011, Hypertension.

[24]  C. Tsioufis,et al.  Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System , 2011, International journal of hypertension.

[25]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[26]  D. Calhoun,et al.  Characterization and treatment of resistant hypertension , 2009, Current cardiology reports.

[27]  Krzysztof Bartus,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.

[28]  E. Muxfeldt,et al.  Prognostic influence of office and ambulatory blood pressures in resistant hypertension. , 2008, Archives of internal medicine.

[29]  J. Staessen,et al.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals , 2007, Journal of hypertension.

[30]  Yutaka Imai,et al.  Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. , 2005, Journal of hypertension.

[31]  G. Parati,et al.  Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis , 2004, Journal of hypertension.

[32]  Jan A Staessen,et al.  Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. , 2004, JAMA.

[33]  Jan A Staessen,et al.  Hypertension prevalence and stroke mortality across populations. , 2003, JAMA.

[34]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[35]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[36]  E. O’Brien,et al.  Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. , 1997, JAMA.

[37]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[38]  E. O’Brien,et al.  Determining the trough-to-peak ratio in parallel-group trials. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. , 1997, Hypertension.

[39]  J. Staessen,et al.  Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis , 1996, Journal of hypertension.

[40]  E. O’Brien,et al.  Ambulatory pressure decreases on long‐term placebo treatment in older patients with isolated systolic hypertension , 1994, Journal of hypertension.

[41]  E. O’Brien,et al.  Technical aspects of ambulatory blood pressure monitoring in the elderly , 1993 .

[42]  F. Mee,et al.  Training and assessment of observers for blood pressure measurement in hypertension research. , 1991, Journal of human hypertension.

[43]  J. Staessen,et al.  Isolated systolic hypertension in the elderly. , 1990, Journal of hypertension.